Insights From Understanding Heterogeneous Trajectories to Kidney Failure

15 Apr 2024 9 a.m. 10:30 a.m.
Hall C4
FacundoDaminato Chairperson Argentina
Magdalena Madero Chairperson Chief of Nephrology, Instituto Nacional de CardiolMexico
PietroRavani Chairperson University of CalgaryCanada
Add to My Schedule

Session Description:
Progression of chronic kidney disease is variable and influenced by many factors. This session will review recent findings related to accelerators and decelerators of CKD progression.
Learning Objectives:
Understand implications of identifying non-neoplastic lesions in nephrectomy samples. Learn about non-cardiovascular events as potential accelerators of CKD progression. Identify medical therapies that are proven to delay CKD progression. Understand the impact of obesity on CKD progression and how new medications for obesity can protect kidney health. 

Time Session
9 a.m.
9:18 a.m.
Non-neoplastic Lesions in Nephrectomy Samples: Implications for Kidney Function
JairMunoz Mendoza Speaker JMMendoza@med.miami.eduUniversity of MiamiUnited States
9:18 a.m.
9:36 a.m.
Understanding the Heterogeneous Trajectory of CKD
MorganGrams Speaker morgan.grams@nyulangone.orgNew York UniversityUnited States
9:36 a.m.
9:54 a.m.
Review of Medical Therapies Proven to Delay CKD Progression
DoreenZhu Speaker doreen.zhu@ndph.ox.ac.ukUniversity of OxfordUnited Kingdom
9:54 a.m.
10:15 a.m.
Impact of Obesity and Novel Treatment Strategies on CKD Progression
PeterRossing Speaker peter.rossing@regionh.dkSteno Diabetes Center Copenhagen Denmark
10:15 a.m.
10:30 a.m.
Q and A